Skip to content
A10109Assembly2019-2020 Session

Decriminalize Buprenorphine Possession

Official title

“Relates to decriminalizing the possession of buprenorphine”

Sponsor Linda RosenthalAD-67Affects Legal
Status
In Assembly Committee
Codes
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Codes

What's happening

This bill decriminalizes the possession of buprenorphine by removing it from the definition of controlled substances in New York.

Why it matters

  1. Reduces criminal penalties for people using buprenorphine. a key medication for opioid addiction treatment—by removing it from New York’s list of controlled substances, making it less risky for individuals to seek or possess this treatment outside of formal medical supervision.

  2. Supports public health and harm reduction strategies. by potentially increasing access to a proven tool for opioid use disorder, which could lower overdose rates and encourage more people to begin or stay in recovery.

  3. Aims to reduce stigma and legal barriers. that deter people from seeking help for addiction, signaling a shift toward treating substance use as a health issue rather than a criminal matter.

  4. May alleviate pressure on the criminal justice system. by reducing arrests and prosecutions related to buprenorphine possession, allowing resources to be redirected to more serious offenses or treatment initiatives.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

Headline styles

Decriminalize Buprenorphine Possession

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Linda Rosenthal

Assembly Member · Assembly District 67

No co-sponsors yet.

History

  1. Referred to codes

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

10109

IN ASSEMBLY

March 12, 2020

Introduced by M. of A. L. ROSENTHAL -- read once and referred to the Committee on Codes

AN ACT to amend the penal law, in relation to decriminalizing the possession of buprenorphine

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivisions 5 and 8 of section 220.00 of the penal law, subdivision 5 as amended by chapter 537 of the laws of 1998 and subdivision 8 as amended by section 18 of part C of chapter 447 of the laws of 2012, are amended to read as follows:

5. "Controlled substance" means any substance listed in schedule I, II, III, IV or V of section thirty-three hundred six of the public health law other than buprenorphine and marihuana, but including concentrated cannabis as defined in paragraph (a) of subdivision four of section thirty-three hundred two of such law.

8. "Narcotic preparation" means any controlled substance listed in schedule II(b-1), III(d) or III(e) other than buprenorphine.

§ 2. This act shall take effect on the first of November next succeeding the date on which it shall have become a law.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD15007-01-0

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.